Arthritis and Rheumatic Diseases

Medicine & Life Sciences

1. Ankylosing Spondylitis 100%
2. Psoriatic Arthritis 53%
3. secukinumab 37%
4. Rheumatoid Arthritis 36%
5. Rheumatology 33%
6. Placebos 32%
7. Tumor Necrosis Factor Inhibitors 29%
8. golimumab 25%
9. ixekizumab 23%
10. Safety 23%
11. guselkumab 18%
12. Therapeutics 17%
13. Systemic Lupus Erythematosus 17%
14. HIV 15%
15. Antirheumatic Agents 15%
16. Psoriasis 15%
17. Interleukin-17 14%
18. upadacitinib 13%
19. Microbiota 12%
20. Rheumatologists 11%
21. Arthritis 11%
22. India 10%
23. Patient Reported Outcome Measures 10%
24. Inflammation 10%
25. Joints 9%
26. Baths 9%
27. Uveitis 9%
28. T-Lymphocytes 9%
29. Shared Decision Making 9%
30. Randomized Controlled Trials 9%
31. Anterior Uveitis 8%
32. Tumor Necrosis Factor-alpha 8%
33. Cytokines 8%
34. Gastrointestinal Microbiome 8%
35. Fibromyalgia 7%
36. Quality of Life 7%
37. HIV-1 7%
38. Fatigue 7%
39. Veterans 6%
40. bimekizumab 6%
41. Pain 6%
42. Sacroiliitis 6%
43. Spine 6%
44. Signs and Symptoms 6%
45. Infections 6%
46. HLA-B27 Antigen 5%
47. HIV Infections 5%
48. Tuberculosis 5%
49. Rheumatic Diseases 5%
50. Back Pain 5%
51. Guidelines 5%
52. Genes 5%
53. Population 5%
54. Vasculitis 5%
55. Sacroiliac Joint 5%
56. Clinical Trials 5%
57. Biological Products 5%
58. Etanercept 5%
59. Infliximab 5%
60. Acquired Immunodeficiency Syndrome 5%